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Neutrophils are recognized as an essential part of the innate immune response, but an 
active debate still exists regarding the life-cycle of these cells. Neutrophils first 
differentiate in the bone-marrow through progenitor intermediaries before entering the 
blood, in a process that gauges the extramedullary pool size. Once believed to be directly 
eliminated in the marrow, liver and spleen after circulating for less than one day, 
neutrophils are now known to redistribute into multiple tissues with poorly understood 
kinetics. This review provides an update on the dynamic distribution of neutrophils across 
tissues in health and disease, and emphasizes differences between humans and model 
organisms. We further highlight issues to be addressed to exploit the neutrophil's unique 
features in the clinic. 
 
The Neutrophil as a Double-Edged Sword in Health and Disease. 
 
Neutrophils (also named polymorphonuclear leukocytes) are phagocytes that play an 
essential role in defending the host against invading pathogens, particularly bacteria and 
fungi [1,2]. The killing of these organisms in phagosomes is mediated by i) fusion with 
lysosomes (granules) liberating cytotoxic proteins, peptides and enzymes into the 
phagolysosome [3], and ii) activation of a membrane-bound NADPH-oxidase producing 
superoxide anions (O2-) that in turn are metabolized into hydrogen peroxide (H2O2) and other 
reactive oxygen species (ROS) [4]. The cells employ these mechanisms both inside the 
phagolysosome as well as outside the cell. In the latter process the fusion of granules 
(degranulation) and activation of NADPH-oxidase localize at the plasma membrane [5,6]. 
The importance of these processes is illustrated by the severe immune deficiencies that in 
man are associated with impaired killing mechanisms in neutrophils, such as those found in 
chronic granulomatous disease (genetic defects in  the multicomponent NADPH-oxidase) 
[7] and Chédiak-Higashi syndrome (granule deficiency) [8] .  
Apart from their essential roles in immune homeostasis, neutrophils are involved in the 
pathogenesis of many inflammatory diseases ranging from acute lung injury following major 
trauma or sepsis, to chronic inflammation in diseases such as chronic obstructive pulmonary 
disease COPD and the many forms of inflammatory arthritis [9,10]. All these clinical 
conditions are associated with the dysregulated migration, activation and survival of 
neutrophils [11].  
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Despite the importance of neutrophils in innate immune responses and their well-recognized 
and deleterious role in inflammatory diseases, surprisingly little is known regarding their life 
span(s) both in time and place, and in health and disease [12,13]. Likewise, it is unclear 
whether heterogeneous neutrophil populations exist, with distinct temporal and anatomical 
properties [10]. However, It is clear, that on the one hand, targeting the full neutrophil 
compartment in inflammatory diseases will cause more problems than solutions. On the 
other hand, if neutrophils could be targeted via disease-specific mechanisms, while leaving 
their major immune and homeostatic functions intact, such interventions would hold 
significant promise in the treatment of a subset of inflammatory diseases,  such as COPD,  
many of which represent a global epidemic in the aging population. To achieve this, it is 
mandatory to understand the basic rules guiding the life cycle of neutrophils in health and 
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Neutrophil Formation and Release from the Bone Marrow 
  
The Mammalian Mitotic Neutrophil Pool 
 
The neutrophil originates from myeloid lineage progenitor cells (common myeloid 
progenitors) located within the bone marrow and extramedullary tissues including the spleen.  
During the initial differentiation steps the myeloid progenitors (myeloblasts) retain their 
propensity to differentiate into both the monocyte/macrophage lineage and the neutrophil 
lineage as well as the other myeloid cells, namely eosinophils and basophils. This common 
differentiation ends with the last progenitor that can differentiate into both lineages, the 
granulocyte macrophage progenitor or GMP [14–19]. Hereafter, the differentiation of 
neutrophils and monocytes (and other myeloid cells) bifurcates from a metastable bipotent 
progenitor (in mice) [20] and the first progenitor that is ‘neutrophil-committed’ is the neutrophil 
pro-myelocyte [21]. This cell-type in humans can be recognized by having a round nucleus 
and a relatively dark cytoplasm (Figure 1) and is able to divide; this is the first neutrophil 
maturation stage of the so-called mitotic neutrophil pool. The number of divisions occurring 
in these pro-myelocytes in humans is unclear as these cells can either proliferate or 
differentiate into the next stage, the myelocyte [18,21]. This cell can be recognized by having 
a round nucleus with an initial dent and less dark cytoplasm compared to the pro-myelocyte. 
It is the last neutrophil maturation stage in the neutrophil lineage that can proliferate, and 
represents the last cell in the mitotic pool (see Figure 1). 
 
Several early studies indicated that human myelocytes [22,23] and possibly pro-myelocytes 
[23] might be heterogeneous in their propensity to divide. It was initially proposed that up to 
50% of these cells proliferate albeit very slowly and are residing in a ‘so-called’ lazy pool 
[22,23]. It is thought that these cells do not contribute greatly to granulopoiesis in 
homeostasis yet provide a means to mobilize neutrophils quickly as/when required by 
accelerated or ‘emergency’ proliferation and differentiation [24]. The presence of a 
putative lazy pool is of key importance for the interpretation of kinetic data obtained by 
cellular modeling as the number of progenitors in cell cycle is much lower than assumed in 
models (see below and [13]).   
 
Recently, several studies have used mass cytometry (CyTOF) and single-cell RNA 
sequencing (scRNA-seq) to re-examine the proliferation and differentiation of the neutrophil 
lineage and have identified (in both mouse and human bone marrow) the presence of 
neutrophil progenitor cells referred to as neutrophil progenitors (preNeu, NeuP or NEP); 
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these appear to be committed, unipotent and early-stage neutrophil progenitors as shown in 
adoptive transfer assays, IdU labeling and determination of cells in cell cycle in vivo applying 
Fucci-474 reporter mouse [16,17,19] . However, these studies did not ‘bench-mark’ these 
cells with the known pro-myelocyte and myelocyte stages as described above. Therefore, it 
remains uncertain whether these progenitors are new/unique or reflect all, or part of, the 
known (pro-) myelocyte pools.  
 
The Post-mitotic Neutrophil Pool 
 
Following the myelocyte stage, the neutrophil progenitors lose their capacity to divide and 
enter the so-called ‘post-mitotic pool’, particularly studied in human cells [25–28]. This 
represents the beginning of a true maturation program starting with meta-myelocytes, which 
in humans are recognized by a kidney shaped nucleus and clear cytoplasm. These cells in 
turn mature into banded cells with a horseshoe-shaped nuclei and again, clear cytoplasm 
(see Figure 1). These cells are not found in the peripheral blood in homeostasis, but can be 
identified in the circulation during periods of acute infection or inflammation, resulting in the 
so-called ‘left-shift’ in the neutrophil population first described by Arneth [29]. The post-
mitotic pool takes around 5-6 days from the last division of the myelocyte to the transition of 
the banded cell into the mature neutrophil in humans (see Figure 1 and [13,25,27,28]). This 
time is significantly shorter (2-3 days) in rodents [30]. 
 
The Mature Neutrophil Pool 
 
Most studies undertaken on neutrophil differentiation to-date consider that the mature 
neutrophil in the bone marrow represents the end of the post-mitotic stage. These studies 
imply that neutrophils undertake terminal differentiation in the bone marrow before being 
liberated into the peripheral blood (see [31]. Some authors suggest that part of the large 
number of human bone marrow neutrophils (7x109/kg body weight) are mobilized as a “rapid 
mobilizable pool” during periods of inflammatory stress [32–34] . However, it is uncertain 
what the fate of these cells is under homeostasis, given that overt apoptosis in the neutrophil 
pool in the bone marrow is a rare event. In support of this concept, a recent study analyzing 
the neutrophil transcriptome and epigenome [35] suggests that the largest differences arising 
during the differentiation of human neutrophils in the bone marrow occurrs during transition 
from the bone marrow mature neutrophil pool to neutrophils in the peripheral blood. 
However, an important caveat of this human study was that the bone marrow and blood cell 
samples were taken from different donors,  and that the isolation procedures differed. This 
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leaves open the distinct possibility that the differences observed were in fact caused by inter-
donor differences and/or ex vivo manipulation of these human cells.  
 
There are further concerns regarding the concept that terminal differentiation of ‘mature’ 
neutrophils is completed in the bone marrow before mobilization to the peripheral blood, as 
mobilization of these cells during acute inflammation should then be associated by 
‘rejuvenation’ in the blood compartment [36]. However, this was not found in one study 
where metabolic labeling of neutrophils in humans in vivo showed that the neutrophils 
mobilized during acute experimental inflammation induced by lipopolysaccharide in human 
volunteer exhibited the same kinetics as mature cells before challenge implying the same 
age post labeling [36]. Hence it is possible that the mature neutrophil compartment behaves 
as a single compartment in full exchange between the blood, bone marrow, and possibly 
other tissue sites such as spleen. This would imply that neutrophilia and the ‘left shift’ seen 
during inflammation might be explained by a mere shift in relative sizes of the pools residing 
in bone marrow and peripheral blood. This shift in cell numbers can indeed quickly normalize 
by remigration of blood cells back to the bone marrow pool upon regaining homeostasis 
[37,38]. This interpretation, however, awaits experimental support.  
 
Differentiation outside of the Bone Marrow 
 
A fascinating issue when considering the life cycle of neutrophils is the possibility that these 
cells might undergo terminal differentiation outside the bone marrow. This concept is still 
hypothetical but is supported by several lines of evidence, including the presence of 
immature progenitors trafficking throughout multiple tissues in mice [39]. This concept 
provides a rationale as to why progenitors are mobilized into the peripheral blood to allow 
alternative imprinting by extramedullary sites. Not much is known about the putative 
underlying mechanisms but neutrophil progenitors have been found in the spleen [40]; it is 
tempting to speculate that tissue-induced, and possibly tissue-selective, alternative imprinting 
can result in the generation of neutrophil subsets with alternative functions, as discussed 
below for the mouse. Indeed, some studies have suggested that neutrophil-myeloid 
derived suppressor cells (granulocyte-MDSC) differentiate in the spleen and may 
contribute to cancer progression [41].  
 
 
Cellular Markers of Different Neutrophil Differentiation Stages in Humans 
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The account of the myeloid lineage described above is descriptive and, until recently, based 
largely on direct microscopic analysis. A rather historic but landmark study [42] reported that 
the absolute number of promyelocytes/myelocytes, metamyelocytes, banded neutrophils and 
mature cells in the bone marrow is remarkably stable, suggesting a ‘conveyor belt-like’ 
model [43]  1964). Another important finding from these early studies was that the total bone 
marrow pool of neutrophils is 6-8 times larger than the total peripheral blood pool [26,42,43].    
Newer technologies based on flow cytometry have confirmed the heterogeneity of 
neutrophils within the bone marrow, but to date, this has not been aligned with the 
corresponding morphology of these populations [44].  A similar type of analysis can be seen 
in Figure 1, which shows that the entire differentiation pathway of human neutrophils can be 
captured using the expression of three cell surface receptors: Mac-1 (CD11b), L-selectin 
(CD62L) and FcɣRIII (CD16). Flow-sorting of the different populations and subsequent 
analysis of the resulting cytospin preparations demonstrates that it is possible to identify and 
isolate the different maturing forms of neutrophils in the bone marrow and peripheral blood. 
Additional markers such as CD10, CD13, CD64 and CD87 can be used to facilitate the 
discrimination between mature and immature neutrophils [45–47].  
 
Such flow technology-based approaches to cell phenotyping can also allow for a more 
accurate quantification of the cell numbers within various differentiation stages in the bone 
marrow. However, the existing studies do not completely align [42,44]. This might reflect the 
fact that bone marrow aspirates are poorly representative of the total cell content of the bone 
marrow consequent upon hemodilution [48] and/or a more sturdy association of progenitors 
with the bone marrow stromal niche, which may serve to trap the more immature dividing 
cells in the stroma. It is of utmost importance to obtain experimental data to determine the 
absolute numbers of neutrophils and neutrophil precursors in bone marrow as this is the 
basis for future models describing differentiation and kinetics of the neutrophil compartment 
(see below). Work in the last decade has demonstrated that the peripheral neutrophil 
compartment is heterogeneous and different populations of cells are characterized by distinct 
nuclear morphologies [11,45,49]. Particularly, human neutrophils with an hyper-segmented 
nucleus have gained interest as they have been shown to have the ability to suppress T-cells 
[45,49], but have lost the capability to intracellularly contain bacteria [50]. The issue of 
neutrophil heterogeneity is beyond the scope of this review and has been addressed by a 
number of recent reviews [2,10,46] and Silvestre-Roig et al. 2019 this series.  
 
 
The Kinetics of Circulating Neutrophils 
Hidalgo et al., The neutrophil life cycle 
 




The Intravascular Neutrophil Pools  
 
Mature neutrophils are present in the vasculature in two pools: a free-flowing intravascular 
blood pool and a blood pool residing in certain tissues. This latter pool is generally referred to 
as the ‘marginated pool’. Early studies suggested that marginated neutrophils were in 
complete equilibrium with the free-flowing cells and, therefore neutrophils from either pool 
were indistinguishable (Athens et al., 1961). The major sites for marginated neutrophils in 
humans are the liver, spleen and bone marrow itself [51], with debate existing as to their 
presence in the lungs, which may be specific only for certain species such as primates, mice 
and dogs [52–54].  
 
The kinetics of circulating neutrophils and neutrophil precursors remains somewhat 
uncertain. In 1929, Weisskotten carried out experiments to determine the kinetics of 
neutrophils in the peripheral blood of rabbits using a toxin, benzol, which specifically targets 
cycling cells [55]. This work concluded that the half-life (t½) of circulating neutrophils in the 
rabbit was 3-4 days. However, this study fell into oblivion as more recent labeling studies did 
not support this relatively long half-life (see below). 
 
Kinetics of Neutrophils in the Peripheral Blood Determined by Reinfusion of Ex Vivo 
Labeled Neutrophils 
 
Important experiments performed in the fifties and sixties, and confirmed recently,  have led 
to the commonly cited belief that circulating human neutrophils are short-lived cells with a t½ 
of 7-9 hours [26,43]. In these experiments ex vivo labeled autologous neutrophils were 
infused into volunteers and the disappearance rate of label in the blood was interpreted as 
representative of the circulatory half-life of these cells. This conclusion was supported by 
metabolic labeling in mice with D2O showing t½ of around 9 -18 hr [12,56]. The interpretation 
of the human data has been challenged by authors who have argued that ex vivo 
manipulation of neutrophils might have changed the homing characteristics of these cells and 
affect their behavior in peripheral blood (see [31]). While deliberate priming of neutrophils 
both ex vivo and in vivo clearly impacts on the distribution of these cells within the 
vasculature, with most neutrophils homing to the lung [57,58], the above data have been 
consistently reproduced using newer techniques that induce minimal-to-no detectable cell 
priming (e.g. [59]). Hence, while priming undoubtedly has a profound impact on the behavior 
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of neutrophils in vivo [60–63], the effect of priming and activation per se on the intravascular 
(circulating, marginated and intra-vascular entrapment e.g. in the pulmonary capillary 
network) half-life of neutrophils has yet to be determined, and much of the above data still 
stands. 
 
Kinetics of Neutrophils in the Peripheral Blood Determined by In Vivo Labeling with 
Radioactive or Stable Isotopes 
 
To circumvent the difficulties of ex vivo cell manipulation, several studies have applied in vivo 
labeling methodologies to track and trace the kinetics of neutrophils. Several labels have 
been used including 3H-thymidine [25], 3H-DFP  and 32P-DFP [43]. These studies have 
produced a slightly more finessed dataset that support both a short as well as a relatively 
long neutrophil lifespan. A short life span in humans is supported by the quick disappearance 
of label in a logarithmic fashion [43]; however, this assumes that the majority of the 
neutrophil compartment is present in the peripheral blood. As discussed above [26,42] the 
majority of the neutrophil compartment resides outside the bloodstream and is likely to be in 
complete exchange, although this remains to be determined. Therefore, the disappearance 
rate of the label might also be explained by a redistribution of the cells into the whole 
neutrophil compartment that could take several hours. Indeed, in a rat model where labeled 
neutrophils were re-infused, it took several hours for neutrophils to end up in the bone 
marrow [37]. Of note, this population of cells that can ‘disappear’ from the circulating 
bloodstream can be mobilized again, as evidenced from bovine experimental models where 
calves were challenged with corticosteroids [64], . These results implied that bone marrow 
margination from the bloodstream seems to occur, rather than the formal uptake of 
neutrophils within a tissue compartment [64]. However, this hypothesis awaits further 
experimental support. In an early study, pulse labeling with 32P-DFP in vivo led to stable 
labeling of blood neutrophils for 11 days, whereas the post-mitotic time was around 5-6 days 
([43] and see below); thus, these data might also be interpreted as supporting a longer half-
life for neutrophils than 7-9 hrs This would support other neutrophil lifespan results indicating 
that these cells can live up to 3-5 days ([12] and below). Nevertheless, it should be noted 
thate experiments applying in vivo 32P-DFP labeling are difficult to repeat/reproduce because 
of ethical constraints.  
  
Fortunately, new technology can re-evaluate these studies by in vivo labeling with the stable 
isotope deuterium (2H) in the form of 2H2O or 2H-6,6-glucose [65]. Under these conditions, 
deuterium is built into the ribose moiety of the DNA of cycling cells including the cells of the 
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mitotic pool of neutrophils progenitors. This technology allows a ‘pulse-chase’ type of 
experiment by following the enrichment of 2H in the DNA, and was only recently applied for 
the analysis of the kinetics of neutrophils in peripheral blood. It concluded that the lifespan of  
human neutrophils in peripheral blood is around 5 days and around 18 hr for murine 
neutrophils [12]. However, the finding for human cells has been challenged by several 
authors [13,66] arguing that the slowness in disappearance of label from the blood could be 
explained by a ‘slow neutrophil compartment’ in the bone marrow and a ‘fast compartment’ in 
the peripheral blood. Indeed, This latter view has been supported by  studies using short 
term labeling with 2H-glucose, which also concluded that human neutrophils have a short 
half-life in peripheral blood [13]. However, these conclusions were based on the assumptions 
that all (pro-) myelocytes divide equally, that neutrophils in the bone marrow and blood do 
not belong to a homogenous pool, that neutrophils do not return to the bone marrow, and 
that there is no lazy-pool of myelocytes [13]. These assumptions are in contrast with data 
showing that rat and human (pro) myelocytes that are dividing keep dividing with a cycle time 
of around 14 hr [67,68], that neutrophils can migrate back to the bone marrow [37,38], and by 
the presence of a so-called ‘lazy neutrophil pool’ [22,23]. In addition, there are kinetic data 
applying metabolic labeling that support the concept that human neutrophils in bone marrow 
and blood belong to the same kinetic pool [69].  
 
In fact, even these published data can be used to support a significantly longer half-life of 
human neutrophils in the peripheral blood as the R-value of 5.5 that leads to an equally good 
fit of the data, supports a t½ of 2.6 days (lifespan of 3.7 days) [13]. It is, however, debatable 
that a model based on ordinary differential equations is the best choice for describing 
neutrophil kinetics as the experimental data are not supportive of a model where all (pro-) 
myelocytes have an equal chance to divide. It seems more likely that only a part of the (pro-) 
myelocyte pool is dividing with a narrow division time supporting a ‘conveyor belt’ type of 
differentiation as suggested before [43], rather than a model based on probabilities. 
From another angle, data obtained in vitro support the hypothesis of prolonged neutrophil 
survival in vivo under conditions of inflammation and argue against a short half life in vivo. 
Multiple mechanisms have been implicated in contributing to prolonged neutrophil survival, 
including hypoxia, the release by inflammatory cells of cytokines and growth factors (e.g. 
GM-CSF and TNF), of microbe associated molecular patterns (e.g. lipopolysaccharide), as 
well as an outcome of viral infections such as with cytomegaly virus and respiratory syncytial 
virus [70–74]. Unfortunately, direct in vivo data in humans are lacking.   
 
Neutrophil Fate and Function within Tissue Compartments 
Hidalgo et al., The neutrophil life cycle 
 
11 | P a g e  
 
 
Dynamics of Neutrophils in Blood and Tissues 
Mouse and human neutrophils newly released into the bloodstream are endowed with 
distinct phenotypic properties in that they gradually change over time following circadian 
oscillations (Adrover, J.M. et al, 2019) and, at least in the mouse, these phenotypic changes 
parallel changes in their transcriptional and migratory properties of neutrophils  (Adrover et 
al., 2019; Adrover et al., 2016) (figure 2). A major functional pathway affected by (circadian) 
time is the rearrangement of the actin cytoskeleton over time, leading to the loss of surface 
microvilli and the subsequent reduction in the capacity of murine neutrophils to roll on 
endothelial selectins at daytime. Ultimately, these types of changes can result in a reduced 
ability to migrate to inflamed tissues over time  (Adrover et al.,  2019). While the mechanisms 
of migration are discussed in more detail in other reviews from this collection  (e.g. Margraf et 
al 2019, and Phillipson et al 2019) , it is important to note that rolling-defective neutrophils 
can still adhere to unstimulated vessels in the dermal microcirculation (and possibly in other 
tissues) in a selectin-independent manner [76],.  The mechanisms involved might be 
potentially similar to those identified for patrolling monocytes [77]. These features might 
explain the efficient entry of neutrophils from blood into naïve tissues, including skin, liver, 
intestine or bone marrow, while sparing tissues generally considered to be immune-
privileged, such as the brain and gonads [78]. However, this warrants further investigation. 
Although similar patterns of recruitment of neutrophils into human tissues have not yet been 
evaluated, similar circadian properties and kinetics of neutrophils have been reported in cells 
from human blood [75]. This suggests that multi-organ infiltration in the steady-state might be 
a conserved feature across species. In addition, indirect demonstration that neutrophils 
infiltrate tissues as part of their natural life cycle comes from studies in mice defective in 
genes needed for neutrophil adhesion and elimination, including integrins, selectins or the 
phagocytic receptor Mertk; these mice have bene found to develop severe alterations in 
granulopoiesis and trafficking of hematopoietic stem and progenitor cells (HSPC), even 
under homeostatic conditions [79,80]. Similar hematopoietic alterations have been found in 
patients bearing leukocyte adhesion deficiency (LAD) mutations [81]; this suggests that a 
similar regulatory loop involving neutrophil migration into naïve tissues might also operate in 
humans, although this remains to be further investigated. Mechanistically, this type of 
regulation in mice appears to be mediated by transcriptional repression of IL-23 in tissue-
resident phagocytes as they take up senescent neutrophils, as shown in vitro studies and 
mice lacking the indicated genes in vivo [79,80,82]. These murine studies have thus 
prompted a renewed interest in defining the dynamics and fate of neutrophils in healthy 
tissues, beyond their lifetime in circulation. 
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Retention and Function of Neutrophils in the Lung Microvascular Bed 
 
While the dynamics of neutrophil entry into naïve or inflamed tissues is increasingly well-
appreciated in the mouse [78], whether and how this occurs in human tissues remains 
largely unknown. Current knowledge in humans largely relies on comparative studies, and 
only in certain organs, such as the lung spleen. For instance, Intravital microscopy studies in 
the murine lung microvasculature have revealed a substantial number of neutrophils within 
the network of small capillary vessels that are rapidly mobilized by the chemokine receptor 
CXCR4 antagonist plerixafor in both mice and primates [52], or which are actively crawling 
on small pulmonary capillaries in mice [83]. Nonetheless, conflicting studies in humans and 
mice debate whether CXCR4 is indeed a retention signal for neutrophils in the lungs [84] and 
further work is required. This margination of circulating neutrophils and intra-vascular 
crawling in murine lungs dramatically increase upon exposure to endotoxin or live bacteria 
relative to naïve mice [83]. Although the size of the intra-vascular marginated neutrophil pool 
in humans is thought to be much smaller than the one shown in mice [85], similar changes in 
surface markers and in the number of circulating human neutrophils have been observed 
after in vivo treatment with endotoxin [83] or platelet-activating factor [57]. This, together with 
the rapid in vitro adhesion of LPS-stimulated human neutrophils to primary pulmonary 
endothelial cells [83], suggests that hypothetically, similar dynamics and intravascular 
behavior might take place in the human lung. In keeping with this notion, humanized sickle-
cell disease (SCD) mice display frequent interactions of neutrophils with platelets within the 
lungs, with formation of microemboli that trigger vaso-occlusive crises and which can 
recapitulate those occurring in SCD patients [86]. These series of findings suggest the 
presence of an abundant population of neutrophils in the resting murine pulmonary 
microcirculation that might potentially serve as a pool for rapid mobilization[52] . The studies 
mentioned above additionally suggest potential roles in local anti-microbial responses, but 
also that they can elicit acute pulmonary injury. Additional studies in the mouse have shown 
that the lung may also provide a site of neutrophil re-programming that enables their return to 
the BM for final elimination [87], while in turn pulmonary neutrophils can instruct 
transcriptional programs in the mouse lungs that influence metastatic invasion [78].   
 
Retention and Function of Neutrophils in the Spleen 
 
The spleen also represents a tissue in which the function of neutrophils has been studied in 
considerable detail both in resting and diseased scenarios. Studies of human spleens 
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demonstrated the presence of at least two populations of neutrophils in the perifollicular zone 
which induce IgM secretion and Ig-class switch in marginal zone B cells through the 
secretion of factors BAFF, APRIL, IL-21 and pentraxin 3 [88,89]. Notably, these neutrophil 
populations in the human spleen were found to be induced post-natally by local signals such 
as IL-10 and GM-CSF, and involved in inducing anti-microbial immunoglobulin production in 
a T cell-independent manner [89]. However, these presumed specialized functions of 
neutrophils in the human spleen could not be reproduced in an independent study [90]. 
Furthermore,a B-helper phenotype similar to that found in the naïve human spleen has been 
reported only in the context of chronic lymphocytic leukemia in the mouse [91], which may 
promote leukemic cell expansion. A recent report demonstrated the presence of additional 
neutrophil populations in the red pulp of the mouse spleen that cleared S. pneumoniae from 
the surface of macrophages, and an additional immature splenic population of neutrophils 
that expanded upon infection with  this bacteria [92]. Thus, resident (and possibly recruited 
and reprogrammed) neutrophil populations appear to be endowed with distinct antimicrobial 
functions in the spleen. Of note, while there is clear evidence from transfer experiments for 
neutrophil accumulation and destruction in the spleen in humans, where approximately 30% 
of all circulating neutrophils end up [93], evidence for the spleen acting as a major site of 
destruction of endogenous neutrophils in mice is lacking. 
 
Uptake and Function of Neutrophils in the Liver 
 
The liver is an organ of active accumulation and destruction of neutrophils. Studies in 
humans have demonstrated rapid accumulation of infused, radio-labeled neutrophils in the 
liver (the ‘hepatic marginated pool’) followed by intense phagocytic uptake, suggested that 
this organ may also be an important site for the homeostatic destruction of neutrophils 
[93,94]. In the rat liver, apoptotic (TUNEL+) neutrophils can be detectable at steady-state, 
but their number escalates dramatically following LPS treatment. Moreover, Kupffer cells 
that line the hepatic sinusoids actively phagocytose phosphatidyl serine (PS)-positive 
neutrophils, while depletion of Kupffer cells re-routes neutrophils to other tissues, such as 
spleen and lungs [95]. These findings agree with the observed accumulation of exogenously-
infused mouse neutrophils mostly in the bone marrow and liver. In this study, immature 
neutrophils preferentially homed back to the bone marrow and these could be re-mobilized to 
sites of infection to participate in anti-microbial defense [96]. Of note, the liver is also a key 
tissue for the elimination of circulating bacteria [97], and neutrophils that have engulfed 
bacteria and die are taken up by Kupffer cells, in a process that blunts production of 
inflammatory cytokines by macrophages and favors resolution of inflammation once the 
Hidalgo et al., The neutrophil life cycle 
 
14 | P a g e  
 
pathogens have been cleared [98]. Thus, the liver represents a primary site of neutrophil 
elimination, however other possible functions for neutrophils within this organ remain to be 
explored. 
 
Migration and Function of Neutrophils in the Bone Marrow 
 
In addition to being the main site of production, the bone marrow is also a site of active 
neutrophil clearance. Studies using mice in parabiosis demonstrated that senescent or aged 
neutrophils could return to the marrow upon completion of their life cycle in blood; this was 
deemed to occur mainly via a CXCR4-dependent mechanism as shown by impaired 
migration of CXCR4 mutant cells to the parabiont’s marrow [38,87,99],. Furthermore, there is 
evidence for active recycling of radiolabeled neutrophils in the human marrow as well [94]. 
Whether this scenario maps equally to humans is yet to be determined as circulating human 
neutrophils express trace amounts of cell surface CXCR4, and studies using ex vivo 
radiolabeled neutrophils suggested that these cells are removed randomly rather than in an 
age-dependent manner [93]. However, various roles of neutrophils in the marrow are 
beginning to emerge, at least in the mouse. For example, aged neutrophils that return to the 
BM after circulating in blood are phagocytosed by medullary macrophages [100], thus 
suppressing CXCL12-producing niche cells, temporally inhibiting the niche’s retention activity 
leading to the circadian release of HSPC into the circulation [99]. Because similar variations 
in circulating HSPC numbers occur in the bone marrow of humans [101], it is reasonable to 
speculate  that they might perform similar suppressive functions, although this remains to be 
investigated.  
 
An important but still poorly-defined issue when considering the fate of neutrophils is their 
actual lifetime within different tissues before final destruction, as this has not been yet 
rigorously measured. Our own preliminary evidence in the mouse suggest dwell times of less 
than one day in the steady-state in certain tissues such as spleen and skin, which may still 
be sufficient to influence many aspects of tissue physiology through the release of cytokines, 
granule proteins, or even NETs as reported in the human spleen [89], but this awaits full 
validation. In other contexts, for example the murine lymph node, our preliminary work, yet to 
be confirmed, suggests much longer tissue residency times than 1 day. Of note, these 
lifetimes can be markedly extended in the context of inflammation, as multiple cytokines and 
bacterial products extend the survival of human and murine neutrophils, at least in part, 
through regulation of the anti-apoptotic factor Mcl-1 [102,103]. Thus, essential features of the 
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neutrophil life cycle, namely their lifespan in different tissues and under inflammatory states, 
remain to date poorly defined and this should be an important task for the coming years. 
 
The Yin and Yang of Neutrophil Targeted Therapies.  
It is noteworthy that several important clinical conditions are associated with either hyper- or 
hypo-activation of the neutrophil compartment. On the one hand, Chronic inflammatory 
diseases such as chronic obstructive pulmonary disease [104] as well as acute inflammatory 
conditions such as systemic inflammatory response syndrome (SIRS) [105,106] are typically 
associated with hyper-activation of neutrophils . Under these conditions, it is possible that 
inhibition of neutrophils may be beneficial for the patient to prevent clinical complications 
brought about by a hyperactive immune system. A similar inhibition of neutrophils might be 
suited for certain cancer patients where activated neutrophils can play a role in suppressing 
anti-tumoral immunity ex vivo such as found in head and neck cancer [107,108].   
On the other hand, insufficient activation of neutrophils in clinical conditions such as in the 
compensatory anti-inflammatory response syndrome (CARS) in patients with multiple injuries 
or following major surgeries can result in the activation of these cells to prevent the 
development of severe infectious complications such as sepsis [109,110]. Nowadays, the 
term CARS is used less often as the hypo-inflammation appears to be initiated alongside the 
SIRS response [111].   The hypothesized rationale for the occurrence of hypo-inflammation 
is that it might limit tissue injury and facilitate healing [112].  However, this remains to be 
directly demonstrated. 
It is clear that the timing of  therapies modulating immune responses is of essence as both 
hypo- and hyper-activation of neutrophils co-exist in patients suffering from acute 
inflammatory conditions [109,113]. A clear example are multi-trauma patients where SIRS is 
dominant during the first days after trauma and a dominant hypo-inflammation becomes 
prominent after several days [114]. Apart from the modulation of activation or inhibition of 
neutrophil responses under these conditions, novel therapies might also be targeted at the 
level of survival/apoptosis [115] of neutrophils; examples may include targeting the pro-
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The variety of kinetics and functions described for neutrophils are consistent with the 
emerging view that these cells are multifaceted. At least part of the neutrophil pool is 
essential in host defense against invading micro-organisms and is crucial for a successful 
immune response. On the negative side, neutrophils are involved in the pathogenesis of a 
plethora of inflammatory diseases, and can additionally, in certain instances, suppress anti-
tumor responses. Thus, it is now clear that neutrophils may become important targets of 
future therapies to suppress hyper-inflammation as well as hypo-inflammation dependent on 
the nature of the disease. Elucidation of the precise mechanisms underlying these 
antagonistic functions might allow the development of new putative therapies that target one 
arm of neutrophil functions while sparing the other arm of their beneficial functions (see 
Outstanding questions). In particular, lessons learned from understanding the lifecycle of 
neutrophils in different states and tissues may translate into clinical benefit; for example, 
manipulation of the life-cycle of neutrophils might potentially allow extending the duration of 
specific beneficial functions, while blocking detrimental functions under pathological 
scenarios. As we continue to better understand the dynamics and physiological facets of 
neutrophils, we hope that new therapeutic strategies will appear that harness the unique 
features of these cells.   
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Box 1. Clinician’s Corner  
• Neutrophils are among the principal effectors of the innate immune response 
and are instrumental in the first line of defense against invading microbes 
• Whilst there may be important differences between human neutrophils and 
those of other mammalian species, much has been learned from studies in 
transgenic animal models 
• The production, circulation and clearance of neutrophils is altered by 
inflammatory stimuli such as those encountered in acute conditions such as 
bacteremia, and chronic conditions such as chronic obstructive pulmonary 
disease 
• Therapies precisely targeted at the deleterious effects of neutrophils, whilst 
leaving beneficial ones intact, will be required for successful manipulation of 
these cells in the clinic 
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Glossary 
CGD, chronic granulomatous disease is an immunodeficiency characterized by mutations in 
genes needed for the generation of reactive oxygen species in granulocytes;  
Chédiak-Higashi syndrome is caused by deficiency in a gene required for lysosomal 
trafficking and phagocytosis that results in immune-deficiency and albinism;  
CMP, or common myeloid progenitors are a type of hematopoietic progenitors that give rise 
to all myeloid-lineage cells in adult hematopoiesis;  
Compensatory anti-inflammatory response syndrome (CARS) is period of systemic 
immune suppression induced by extensive tissue damage or uncontrolled infections. SIRS 
and CARS can co-exist.   
Conveyor belt-like model, a model of granulopoiesis in which immature, but not 
proliferative, neutrophils give rise to a progressively mature  neutrophil;  
CyTOF or mass cytometry is a technique that combines mass spectrometry and flow 
cytometry thus allowing multiparametric (>30) assessment of cell markers;  
Cytospin a preparation of cells that have been centrifuged on a slide for staining and 
morphological evaluation;  
Endothelial selectins, are two receptors  (E- and P-selectins) present on endothelial cells 
that enable leukocyte rolling under flow conditions Granulocyte-MDSC, or granulocytic 
myeloid-derived suppressor cells is a subset of neutrophils with T cell-suppressive activity;  
Granule proteins is a group of enzymes and anti-microbial proteins found within cytoplasmic 
granules;  
Granulopoiesis, refers to the process of proliferation and differentiation of granulocyte 
progenitors into mature cells;   
Hematopoietic stem and progenitor cells (HPSC) are a rare population of hematopoietic 
cells that can give rise to all blood lineages;  
Hepatic marginated pool, is the group of leukocytes found within the liver microvasculature; 
Intravascular crawling, is a type of cell migration on the endothelial surface;  
Kupffer cells, macrophages of the liver;  
Lazy pool, is a subset of neutrophil progenitors that rarely divide in the steady-state but 
activate upon acute demand for granulopoiesis;  
Left-shift, refers to the process of mobilization of immature neutrophils in the 
peripheral blood;  
Leukocyte adhesion deficiency, a group of genetic disorders that affect the capacity of 
leukocytes to roll or adhere on the vascular endothelium;  
Marginal zone of the spleen is regions at the interface between the lymphoid white pulp and 
the non-lymphoid, macrophage-rich red pulp. 
Marginated pool, a population of intravascular neutrophils that is adhered to the endothelial 
lining and is not free flowing in the bloodstream;  
NETs, or neutrophil extracellular traps are DNA-based structures that are released by 
activated neutrophils and have microbicidal and pro-thrombotic properties.  
Neutrophil progenitors, are a group of hematopoietic cells that are already committed to 
the neutrophil lineage by successive proliferation and/or differentiation;  
Neutrophil rejuvenation refers to the appearance of immature forms of neutrophils in the 
blood after release in the bloodstream;  
Neutrophil re-programming, is a theoretical phenomenon whereby neutrophils change their 
phenotype and function;  
Priming, an intermediate activation state of neutrophils that involves active intracellular 
signaling;  
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Pulse-chase experiment, an approach typically based on metabolic labeling of cells to 
follow their dynamics in live animals  
Rapid mobilizable pool, is a population of neutrophils in the bone marrow that are rapidly 
mobilized into the circulation during stress conditions;;  
Rolling-defective neutrophils, are neutrophils that lack the glycoprotein ligands that 
engage selectins during the rolling process;  
R-value is the ratio of blood neutrophils to mitotic precursors in the bone marrow; 
Systemic inflammatory response syndrome (SIRS) is a period characterized by enhanced 
levels of systemic inflammatory signals caused by extensive tissue damage or uncontrolled 
infections;  
TUNEL, orTerminal deoxynucleotidyl transferase (TdT) dUTP Nick-End Labeling assay is a 
method that detects early apoptosis in cells that undergo extensive DNA degradation  
Parabiosis is an experimental system that allows the study of shared exchange of circulatory 
molecules or cells between organisms, and normally achieved by surgical conjoining of the 
circulatory systems. 
 
Table I: Relevant differences between murine and human immune systems 




10-25% 50-70%  
Neutrophil size 8.64 ± 0.14 µM 10.39 ± 0.19 µM [118] 
Nuclear morphology Ring-like Segmented [119] 
Neutrophil granule 
contents 
Defensins absent; low 





Defensins present; high 









CCL6, CCL9, CXCL15, 
CCL12 found in mice, but 
not humans 
CXCR1, CXCL8, CXCL7, 
CXCL11, CCL13. CCL14, 
CCL15, CCL18, CCL23, 
CCL24/CCL26 found in 




Express Gr-1 and Ly-6G Absent [122] 
Different Fc receptor 
expression 
Do not express FcaRI  
Do not express FcgRI 
Express FcaRI  
Inducible expression of 
FcgRI 
[123–125] 
Affinity of fMLF 
receptor 
Low High [126] 
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Figure 1: Differentiation of the neutrophil compartment in the human bone marrow 
 
A. Model for neutrophil differentiation in the bone marrow. In this model differentiation of 
neutrophil and its progenitors behaves like a conveyor belt as firstly suggested by Cartwright 
et al. [43]. Neutrophil committed differentiation starts with the neutrophilic promyelocyte and 
myelocyte that both have the propensity to divide and as such are part of the mitotic pool. 
Hereafter, the cells stop dividing and mature into metamyelocytes and band neutrophils both 
of which are not found in the peripheral blood (i.e. post-mitotic pool). Hereafter, the cells 
enter the mature state in which they are in exchange between bone marrow, blood and other 
tissues. 
B. Differences in marker expression of differentiating neutrophils in bone marrow. The 
neutrophil lineage in the bone marrow can be visualized flow cytometry and sorted on scatter 
characteristics and the expression of three markers: Mac-1 (CD11b), FcɣRIII (CD16) and L-
selectin (CD62L). Examples of cytometry contour plots are shown. The dump gate was 
designed by applying next to forward scatter (FSC)  and side scatter (SSC)  co-staining with 
CD193, CD56 and HLA-DR antibodies. Cytospins are shown of the cells sorted from the 
indicated gates.   
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Key Figure, Figure 2: Neutrophil fates within tissue compartments 
 
Neutrophils produced in the BM and released into the circulation can enter multiple tissues 
after a process of diurnal aging (oscillations in phenotype), even in the absence of 
inflammatory stimuli. In these tissues they play prominent roles related to anti-microbial 
defense, immune cell maturation, regulation of stem cell niches, or are ultimately eliminated. 
For example, while in the BM granulopoiesis and vascular regeneration may represent 
relevant functions before they are released into blood, neutrophils acquire the capacity to 
regulate the circadian release of hematopoietic stem and progenitor cells (HSPC) when they 
return to the marrow for elimination. Similarly, specialized functions in the spleen for B cell 
maturation or in the lungs for immune surveillance suggest a wealth of functions tailored to 
each tissue as detailed in the text. HSPC, hematopoietic stem and progenitor cell; Ig, 




• Neutrophils are produced by committed progenitors in the bone marrow and some 
extramedullary tissues 
• The lifetime of mammalian neutrophils remains controversial  
• Neutrophils are found in most healthy tissues at varying numbers  
• Manipulation of the neutrophil life-cycle may be a promising strategy for the treatment 
of inflammatory diseases   
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Outstanding questions box  
• What are the real transit times of neutrophils in blood, bone marrow and 
tissues? These times may provide insights into non-immune roles and the 
pathogenic potential of neutrophils in tissues. 
• What is the evolutionary basis for the diurnal behavior of neutrophils? Gating 
anti-microbial functions or protecting the host’s tissues are possible benefits of 
this behavior.  
• What are the mechanisms of neutrophil clearance in mice and humans? In 
which tissues does clearance occur? Understanding such mechanisms may 
enable extension or reduction of the number of neutrophils depending on 
clinical needs. 
• Can the life cycle of neutrophils be reprogrammed or manipulated for the 
clinic? In what ways? Rewiring epigenetic and transcriptional programs in 
neutrophils may confer protection from derailed inflammation or against 
unwanted immune suppression in cancer. 
• What is the role of the large marginated pools of neutrophils that reside under 
physiological conditions in the liver and the spleen? Responding this question 
may provide a rational to induce the mobilization of these physiological stores. 
• How do viruses and bacteria subvert the life cycle of neutrophils? This is a 
critical question to define how pathogens may co-opt neutrophils for 
propagation. 
 
 
 
